Binge-eating disorder relapse risk with lisdexamfetamine was markedly lower than with placebo.
Binge eating disorder is the most common eating disorder in adults and has the potential for serious health implications if left untreated.
Researchers have assessed the questionnaire's ability to identify binge eating disorder.
It is important to recognize symptoms of binge eating disorder and have a conversation with your family doctor about your relationship with food.
Pharmacological and optogenetic inhibition of ventral pallidum neurons during cue presentation impedes reward-seeking behavior.
Mental health conditions, like binge eating disorder and depression, are common among patients undergoing bariatric surgery.
Lifetime prevalence of developing diabetes in this population highest among males.
The Binge Eating Disorder Screener-7 (BEDS-7) is a concise, patient-reported screening tool.
Mean one-year health care costs for a binge eating patient was $33,716, compared with $19,548 for patients without an eating disorder.
Patients taking Vyvanse experienced a decrease in the number of binge eating days per week.
In higher doses, Vyvanse (lisdexamfetamine dimesylate) helped to curb binge eating.
Psychotherapy is useful in treating bulimia and binge eating, while anorexia remains the most difficult eating disorder to tackle.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Family History of Psychiatric Disorders an Important Predictor of Postpartum Psychiatric Illness
- New APA President Takes Office as the First African-American to Lead the Organization
- MDMA-Assisted Psychotherapy Effective for Treating PTSD in Veterans, First Responders
- Antidepressant Use May Be Linked With Sustained Risk for Weight Gain
- Early Intervention Services Superior to Treatment as Usual for Early-Phase Psychosis
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- Cannabidiol Not Associated With Improvement in Chronic Schizophrenia
- New Dimensions in Psychopathy: Are There Cultural Differences in Psychopaths?
- Addressing Psychiatric Comorbidities in Inflammatory Rheumatic Diseases
- Exploring the Link Between Persistent Infection, Inflammation, and Mood Disorders
- CDC: No Change in Level of Uninsured in US in 2017
- Benefit of Behavioral Activation During TMS for Major Depressive Disorder